1. Katoh, Masuko, Katoh, Masaru. . Human FOX gene family (Review). In International journal of oncology, 25, 1495-500. doi:. https://pubmed.ncbi.nlm.nih.gov/15492844/
2. Xiang, Jun, Wen, Fang, Zhang, Lingyun, Zhou, Yu. 2017. FOXD3 inhibits SCN2A gene transcription in intractable epilepsy cell models. In Experimental neurology, 302, 14-21. doi:10.1016/j.expneurol.2017.12.012. https://pubmed.ncbi.nlm.nih.gov/29288635/
3. Liu, Ruimin, Sun, Yan, Chen, Shuai, Hong, Yun, Lu, Zhongxian. 2022. FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis. In The FEBS journal, 289, 4536-4548. doi:10.1111/febs.16403. https://pubmed.ncbi.nlm.nih.gov/35178865/
4. Luo, Gui-Fang, Chen, Chang-Ye, Wang, Juan, Li, Yu-Kun, Li, Yan. 2019. FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer. In Cancer cell international, 19, 44. doi:10.1186/s12935-019-0755-8. https://pubmed.ncbi.nlm.nih.gov/30858761/
5. E, Zhang, Li, Chunli, Xiang, Yuandi. 2020. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells. In Open medicine (Warsaw, Poland), 15, 1193-1201. doi:10.1515/med-2020-0177. https://pubmed.ncbi.nlm.nih.gov/33336076/
6. Yin, Huabin, Meng, Tong, Zhou, Lei, Chen, Haiyan, Song, Dianwen. . FOXD3 regulates anaplastic thyroid cancer progression. In Oncotarget, 8, 33644-33651. doi:10.18632/oncotarget.16853. https://pubmed.ncbi.nlm.nih.gov/28430585/